You ask the questions - we develop the answers.

We combine professional management with scientific expertise.

The Institute for Pharmacology and Preventive Medicine

The Institute is an experienced partner of universities, non-university institutions, health insurance companies, and pharmaceutical companies in the implementation of scientific projects in the fields of cardiovascular disease and diabetes.

Icon Beratung


We offer the trustworthy advice of a medical doctor and a pharmacist.

read more

Icon Klinische Register

Clinical Registries

Clinical registries across Europe are our primary area of expertise.

read more

Icon Prüfzentrum

Validation Centre

We will test and validate your blood pressure monitors.

read more

IPPMed Partnership

Prof. Dr. Peter Bramlage (physician) and Dr. Johannes Hankowitz (pharmacist) work closely together in the Institute for Pharmacology and Preventive Medicine, Dr. Bramlage & Dr. Hankowitz Partnership. Dr Bramlage focuses on collaboration with partners from industry and universities on scientific questions and the evaluation and publication of study data. Dr Hankowitz is experienced in the preparation and assessment of drug evaluations within the AMNOG (Pharmaceuticals Market Reorganisation Act).


Our activities in the areas of clinical registries and validation of blood pressure monitoring devices are a part of IPPMed – Institute for Pharmacology and Preventive Medicine GmbH. This is managed by Prof. Dr. Peter Bramlage and Beate Beime. Here, together with the highly experienced staff at our office in Cloppenburg, we regularly carry out large scale projects involving the latest pharmaceuticals and medical devices.
The close collaboration with clients, as well as with external investigators, ensures the high quality of our work. We focus primarily on cardiovascular indications, hypertension, thrombosis, and diabetes.

Scientist / Physician wanted!
Medical Writer wanted!

To enhance our scientific output we are looking for an experienced scientist with cardiovascular disease experience as well as a (native English) Medical Writer.

Recent Activity / Publications in press

Cohen AT, Ay C, Hainaut P, Décousus H, Hoffmann U, Gaine S, Coppens M, da Silva PM, Jimenez Castro D, Amann-Vesti B, Brüggenjürgen B, Levy P, Lopez Bastida J, Vicaut E, Laeis P, Fronk EM, Zierhut W, Malzer T, Bramlage P, Agnelli G. Design and rationale of the non-interventional, Edoxaban Treatment in routiNe clinical prActice in patients with Venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study. Thrombosis Journal 2018.

Asteggiano R, Bramlage P, Richter DJ. European Society of Cardiology Council for Cardiology Practice worldwide survey of TAVI beliefs and practices. Eur J Prev Cardiol 2018.

Bramlage P, Schmidt S, Sims H. Fixed-dose vs. free-dose combinations for the management of hypertension – an analysis of 81,958 patients. J Clin Hypertens 2018.

Leigh MB, John-Cole V, Kamara M, Koroma AP, Koroma MM, Eumuveyan EE, Bramlage P, Buschmann I. A Triple Obstetric Challenge of Thoracopagus-Type Conjoined Twins, Eclampsia and Obstructed Labor: A Case Report from sub-Saharan Africa. Case Rep Obstetr Gynecol 2017; 6815748.

Schmieder RE, Tschöpe D, Koch C, Ouarrak T, Gitt AK; DIALOGUE study Group. Individualised Treatment Targets in patients with type-2 Diabetes and Hypertension. Cardiovasc Diabetol 2018;17:18.

Kowalski M, Deutsch C, Hofmann S, Franz N, Billion M, Ferdosi A, Bramlage P, Imnadze G, Warnecke H. Transcatheter aortic valve implantation at a high-volume center: the Bad Rothenfelde experience. Polish J Thorac Cardiovasc Surg 2017.

Ungar A, Mannarino G, van der Velde N, Baan J, Thibodeau MP, Masson JB, Santoro G, van Mourik M, Jansen S, Deutsch C, Bramlage P, Kurucova J, Thoenes M, Maggi S, Schoenenberger AW. Comprehensive geriatric assessment in patients undergoing transcatheter aortic valve implantation – results from the CGA-TAVI multicentre registry. BMC Cardiovas Disord 2018.

Veröffentlichungen mit PubMed Listung

Our Partners

Logo da-cro
Logo IHF
logo Beate Beime Pharma Consulting